drugset / Trial / NCT00790881
Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults
Phase 4
Completed
36 enrolled
University of Cape Town
London School of Hygiene and Tropical Medicine · collab
Parallel-groupOpen-labelTreatment
Summary
Despite the clinical significance of potential interactions between antimalarials and antiretrovirals, no drug interaction studies have been published and there is an urgent need to address this gap in current knowledge. This study aims to assess the drug interaction between the antimalarial Artemether/Lumefantrine used for management of uncomplicated malaria and Nevirapine-based antiretroviral therapy.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-08
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artemether | Small molecule | 80 mg | — |
| Subject | lumefantrine | Small molecule | 480 mg | — |